Susan Harnan - Publications 

Journal articles

Conference proceedings papers

  • Harnan S, Essat M, Gomersall T, Tappenden P, Wong R, Lawson R, Pavord I & Everard M (2015) Exhaled Nitric Oxide For The Diagnosis Of Asthma In Adults And Children: A Systematic Review. Value in Health, Vol. 18(7) (pp A345-A345)
  • Harnan S, Ren S, Gomersall T, Everson-Hock E, Sutton A, Dhanasiri S & Kulasekararaj A (2014) Systematic Review and Meta-Analysis of the Association Between Transfusion Independence (TI) and Overall Survival (OS) in Patients (pts) with Myelodysplastic Syndromes (MDS). BLOOD, Vol. 124(21)
  • Tappenden P, Harnan S, Uttley L, Mildred M, Taylor CJ, Brownlee K & Walshaw M (2013) THE COST-EFFECTIVENESS OF DRY POWDER ANTIBIOTICS FOR THE TREATMENT OF PSEUDOMONAS AERUGINOSA IN PATIENTS WITH CYSTIC FIBROSIS. VALUE IN HEALTH, Vol. 16(7) (pp A372-A372)
  • Harnan SE, Uttley L, Cantrell A, Taylor CJ, Walshaw M, Brownlee K & Tappenden P (2013) SYSTEMATIC REVIEW OF COLISTIMETHATE SODIUM DRY POWDER AND TOBRAMYCIN DRY POWDER ANTIBIOTICS FOR PSEUDOMONAS AERUGINOSA LUNG INFECTION IN CYSTIC FIBROSIS. VALUE IN HEALTH, Vol. 16(7) (pp A367-A367)
  • Meng Y, Squires H, Stevens JW, Simpson E, Harnan S, Thomas S, Michaels J, Stansby G & O'Donnell M (2012) COST-EFFECTIVENESS OF CILOSTAZOL, NAFTIDROFURYL OXALATE, PENTOXIFYLLINE AND INOSITOL NICOTINATE FOR THE TREATMENT OF INTERMITTENT CLAUDICATION IN PEOPLE WITH PERIPHERAL ARTERIAL DISEASE IN THE UK. VALUE IN HEALTH, Vol. 15(7) (pp A633-A633)
  • Pandor A, Harnan SE, Goodacre SW, Pickering A, Fitzgerald P & Rees AC (2011) DIAGNOSTIC ACCURACY OF CLINICAL CHARACTERISTICS FOLLOWING MINOR HEAD INJURY: A SYSTEMATIC REVIEW AND META-ANALYSIS. VALUE IN HEALTH, Vol. 14(7) (pp A245-A245)
  • Harnan SE, Pickering A, Pandor A & Goodacre SW (2011) CLINICAL DECISION RULES FOR ADULTS WITH MINOR HEAD INJURY: A SYSTEMATIC REVIEW. VALUE IN HEALTH, Vol. 14(7) (pp A244-A244)
  • Meng Y, Ward SE, Cooper K, Harnan SE & Wyld L (2011) THE POTENTIAL ROLE OF MAGNETIC RESONANCE IMAGING (MRI) IN AXILLARY NODE ASSESSMENT OF EARLY BREAST CANCER: AN ECONOMIC EVALUATION. VALUE IN HEALTH, Vol. 14(7) (pp A253-A253)
  • Pickering A, Fitzgerald P, Harnan SE, Pandor A & Goodacre SW (2011) BIOCHEMICAL MARKERS FOR THE IDENTIFICATION OF INTRACRANIAL INJURY FOLLOWING MINOR HEAD INJURY: A SYSTEMATIC REVIEW AND META-ANALYSIS. VALUE IN HEALTH, Vol. 14(7) (pp A244-A244)
  • Harnan SE, Jorgensen A, Tsuchiya A, Goyder L & Woods HB (2011) TOWARDS COST-EFFECTIVENESS ANALYSIS OF THE HEALTH AND WELLBEING BENEFITS OF URBAN GREEN SPACE: A MAPPING REVIEW. VALUE IN HEALTH, Vol. 14(7) (pp A343-A343)
  • Meng Y, Ward S, Cooper K, Harnan S & Wyld L (2010) Cost-effectiveness assessment of pet and mri for the evaluation of axillary lymphnode metastases in breast cancer: A discrete event simulation model. Proceedings of the 2010 Operational Research Society Simulation Workshop, SW 2010 (pp 49-58)
  • White S, Mason S, Parker A, Harnan S, Davis B, ChessWilliams R & Woolf A (1997) alpha(1B)-adrenoceptor affinity and density differentiated and undifferentiated mouse glomerular mesangial cells.. J AM SOC NEPHROL, Vol. 8 (pp A1432-A1432)
  • BLEAKMAN D, PEARSON K, HARNAN S, KAMBOJ R & SCHOEPP D (1995) EFFECTS OF LY293558 AND NBQX ON GLUTAMATE-RECEPTOR RESPONSES IN RAT CEREBELLAR PURKINJE NEURONS AND HEK293 CELLS EXPRESSING THE HUMAN GLUR6 GLUTAMATE-RECEPTOR. BRIT J PHARMACOL, Vol. 115 (pp P112-P112)

Reports

  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix I - Schizophrenia View this article in WRRO
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix H - Psychological Therapies View this article in WRRO
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix G - Head and Neck Cancer. View this article in WRRO
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix E - Diabetes View this article in WRRO
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) . Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer. View this article in WRRO
  • Ara , Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy View this article in WRRO
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the collection patient reported outcome measures in the National Clinical Audits for assessing costeffectiveness Work Package 1. What patient reported outcome measures should be used in the 13 health conditions specified in the 2013/14 National Clinical Audit programme? APPENDIX C, INFLAMMATORY BOWEL DISEASE View this article in WRRO
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix J - Dementia. View this article in WRRO
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix K - Cardiovascular. View this article in WRRO
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. View this article in WRRO

Posters

  • Pickering A, Harnan S, Pandor A, Fitzgerald P & Goodacre S (2010) Clinical Decision Rules for children with minor head injury: A systematic review. European Society of Emergency Medicine,(EuSEM) Stockholm.